Standard
Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans. / Meier, Juris J; Ritter, Peter R; Jacob, Alexandra; Menge, Bjoern A; Deacon, Carolyn F; Schmidt, Wolfgang E; Nauck, Michael A; Holst, Jens J.
In:
Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 8, 01.08.2010, p. 4061-5.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Meier, JJ, Ritter, PR, Jacob, A, Menge, BA
, Deacon, CF, Schmidt, WE, Nauck, MA
& Holst, JJ 2010, '
Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans',
Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 8, pp. 4061-5.
https://doi.org/10.1210/jc.2010-0550APA
Meier, J. J., Ritter, P. R., Jacob, A., Menge, B. A.
, Deacon, C. F., Schmidt, W. E., Nauck, M. A.
, & Holst, J. J. (2010).
Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.
Journal of Clinical Endocrinology and Metabolism,
95(8), 4061-5.
https://doi.org/10.1210/jc.2010-0550Vancouver
Meier JJ, Ritter PR, Jacob A, Menge BA
, Deacon CF, Schmidt WE et al.
Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.
Journal of Clinical Endocrinology and Metabolism. 2010 Aug 1;95(8):4061-5.
https://doi.org/10.1210/jc.2010-0550Author
Meier, Juris J ; Ritter, Peter R ; Jacob, Alexandra ; Menge, Bjoern A ; Deacon, Carolyn F ; Schmidt, Wolfgang E ; Nauck, Michael A ; Holst, Jens J. / Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 8. pp. 4061-5.
Bibtex
@article{3629b445e2904755a6a31df36515b72e,
title = "Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans",
abstract = "Postprandial secretion of glucagon-like peptide 1 (GLP-1) has been found diminished in some patients with type 2 diabetes mellitus (T2DM) and high glucagon concentrations. We examined the effects of exogenous glucagon on the release of incretin hormones.",
keywords = "Aged, Analysis of Variance, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Female, Gastric Inhibitory Polypeptide, Glucagon, Glucagon-Like Peptide 1, Humans, Incretins, Insulin, Male, Middle Aged, Postprandial Period",
author = "Meier, {Juris J} and Ritter, {Peter R} and Alexandra Jacob and Menge, {Bjoern A} and Deacon, {Carolyn F} and Schmidt, {Wolfgang E} and Nauck, {Michael A} and Holst, {Jens J}",
year = "2010",
month = aug,
day = "1",
doi = "10.1210/jc.2010-0550",
language = "English",
volume = "95",
pages = "4061--5",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "8",
}
RIS
TY - JOUR
T1 - Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans
AU - Meier, Juris J
AU - Ritter, Peter R
AU - Jacob, Alexandra
AU - Menge, Bjoern A
AU - Deacon, Carolyn F
AU - Schmidt, Wolfgang E
AU - Nauck, Michael A
AU - Holst, Jens J
PY - 2010/8/1
Y1 - 2010/8/1
N2 - Postprandial secretion of glucagon-like peptide 1 (GLP-1) has been found diminished in some patients with type 2 diabetes mellitus (T2DM) and high glucagon concentrations. We examined the effects of exogenous glucagon on the release of incretin hormones.
AB - Postprandial secretion of glucagon-like peptide 1 (GLP-1) has been found diminished in some patients with type 2 diabetes mellitus (T2DM) and high glucagon concentrations. We examined the effects of exogenous glucagon on the release of incretin hormones.
KW - Aged
KW - Analysis of Variance
KW - Blood Glucose
KW - C-Peptide
KW - Diabetes Mellitus, Type 2
KW - Female
KW - Gastric Inhibitory Polypeptide
KW - Glucagon
KW - Glucagon-Like Peptide 1
KW - Humans
KW - Incretins
KW - Insulin
KW - Male
KW - Middle Aged
KW - Postprandial Period
U2 - 10.1210/jc.2010-0550
DO - 10.1210/jc.2010-0550
M3 - Journal article
C2 - 20501678
VL - 95
SP - 4061
EP - 4065
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 8
ER -
